1. Home
  2. SGRY vs NBTX Comparison

SGRY vs NBTX Comparison

Compare SGRY & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Surgery Partners Inc.

SGRY

Surgery Partners Inc.

HOLD

Current Price

$15.49

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$38.54

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGRY
NBTX
Founded
2004
2003
Country
United States
France
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
SGRY
NBTX
Price
$15.49
$38.54
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$22.25
$36.00
AVG Volume (30 Days)
1.4M
112.4K
Earning Date
05-05-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
54.14
N/A
EPS
N/A
N/A
Revenue
$1,145,438,000.00
N/A
Revenue This Year
$5.09
$58.17
Revenue Next Year
$5.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.41
$6.09
52 Week High
$24.10
$57.14

Technical Indicators

Market Signals
Indicator
SGRY
NBTX
Relative Strength Index (RSI) 48.06 50.06
Support Level $15.06 $30.15
Resistance Level $16.44 $42.40
Average True Range (ATR) 0.87 2.32
MACD -0.10 -0.05
Stochastic Oscillator 38.90 50.34

Price Performance

Historical Comparison
SGRY
NBTX

About SGRY Surgery Partners Inc.

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: